ChiCTR2400087409 版本V1.1 版本创建时间2026/02/03 16:13:27 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400087409 

最近更新日期:

Date of Last Refreshed on:

2024-07-26 11:41:49 

注册时间:

Date of Registration:

2024-07-26 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于肺静态顺应性的个体化peep滴定对Trendelenburg体位腹腔镜手术老年患者肺保护作用研究

Public title:

Effect of static lung compliance-guided positive end-expiratory pressure on postoperative pulmonary complications in elderly patients undergoing laparoscopic surgery in trendelenburg position

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于肺静态顺应性的个体化peep滴定对Trendelenburg体位腹腔镜手术老年患者肺保护作用研究

Scientific title:

Effect of static lung compliance-guided positive end-expiratory pressure on postoperative pulmonary complications in elderly patients undergoing laparoscopic surgery in trendelenburg position

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王秀芹 

研究负责人:

王秀芹 

Applicant:

Xiuqin Wang 

Study leader:

Xiuqin Wang 

申请注册联系人电话:

Applicant telephone:

+86 531 6762 6222

研究负责人电话:

Study leader's telephone:

+86 531 6762 6222

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangxiuqin@sdfmu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

wangxiuqin@sdfmu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省济南市济兖路440号

研究负责人通讯地址:

山东省济南市济兖路440号

Applicant address:

440 Jyan Road, Jinan City, Shandong Province

Study leader's address:

440 Jyan Road, Jinan City, Shandong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

山东第一医科大学附属山东省肿瘤医院

Applicant's institution:

Shandong Cancer Hospital and Institute A?liated to Shandong First Medical University (Shandong Academy of Medical Science)

研究负责人所在单位:

山东第一医科大学附属山东省肿瘤医院

Affiliation of the Leader:

Shandong Cancer Hospital and Institute A?liated to Shandong First Medical University (Shandong Academy of Medical Science)

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

SDTHEC2024007022

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

山东第一医科大学附属肿瘤医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shandong First Medical University Affiliated Cancer Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-07-15 00:00:00

伦理委员会联系人:

宋现让

Contact Name of the ethic committee:

Xianrang Song

伦理委员会联系地址:

山东省济南市济兖路440号

Contact Address of the ethic committee:

440 Jiyan Road, Ji'nan, Shandong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 531 6762 6777

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

山东第一医科大学附属山东省肿瘤医院

Primary sponsor:

Department of Anesthesiology, Shandong Cancer Hospital and Institute A?liated to Shandong First Medical University

研究实施负责(组长)单位地址:

山东省济南市济兖路440号

Primary sponsor's address:

440 Jiyan Road, Ji'nan, Shandong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东省

市(区县):

Country:

China

Province:

Shandong

City:

单位(医院):

山东第一医科大学附属山东省肿瘤医院

具体地址:

山东省济南市济兖路440号

Institution
hospital:

Shandong Cancer Hospital and Institute A?liated to Shandong First Medical University (Shandong Academy of Medical Science

Address:

440 Jiyan Road, Ji'nan, Shandong, China

经费或物资来源:

自筹经费

Source(s) of funding:

Self funding

Target disease:

lung injury

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

研究基于肺静态顺应性的个体化peep滴定对Trendelenburg体位腹腔镜手术老年患者肺保护作用  

Objectives of Study:

To investigate the effect of static lung compliance-guided positive end-expiratory pressure on postoperative pulmonary complications in elderly patients undergoing laparoscopic surgery in trendelenburg position

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

择期在我院行Trendelenburg体位腹腔镜手术老年患者预计手术时长大于≥2小时,年龄65-80岁,ASAⅠ-Ⅲ,BMI19-28kg/m2,

Inclusion criteria

(1)For elective laparoscopic surgery in trendelenburg position and duration of surgeru≥2 hour (2) ASA grade I-III patients (3) Body mass index,(BMI) 19-28kg/m2 (4) 65-80 years old

排除标准:

1 合并严重的呼吸系统并发症,包括慢性阻塞性肺疾病、哮喘、支气管扩张、肺炎、OSAHS、肺间质纤维化、 2 肺部手术史,或心肺损伤等; 3 合并严重心血管疾病,包括心力衰竭、各类心律失常、冠状动脉粥样硬化性心脏病、各类心肌疾病、先心病及心脏瓣膜病等;肾脏疾病,肝脏疾病(血清总胆红素≥2mg/dl)

Exclusion criteria:

1. Preoperative pulmonary inflammation, pulmonary edema, emphysema, chronic obstructive pulmonary disease or diaphragmatic dysfunction;OSAHS, asthma; 2. Previous history of intrathoracic surgery or cardiopulmonary injury; 3. severe cardiovascular diseases (such as myocardial infarction, heart failure, malignant arrhythmia, etc.) , renal diseases, liver diseases, diseases (serum total bilirubin ≥2 mg/dl)

研究实施时间:

Study execute time:

From 2024-07-31 00:00:00 To 2025-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-08-01 00:00:00 To 2025-05-31 00:00:00  

干预措施:

Interventions:

组别:

个体化PEEP组

样本量:

35

Group:

PEEP

Sample size:

干预措施:

个体化设定PEEP

干预措施代码:

Intervention:

static lung compliance-guided positive end-expiratory pressure

Intervention code:

组别:

固定PEEP组

样本量:

35

Group:

Fixed PEEP group

Sample size:

干预措施:

固定PEEP

干预措施代码:

Intervention:

PEEP=4cmH2O

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东 

市(区县):

 

Country:

China  

Province:

Shandong 

City:

 

单位(医院):

山东第一医科大学附属山东省肿瘤医院 

单位级别:

三甲 

Institution
hospital:

Shandong Cancer Hospital and Institute Affliated to Shandong First Medical University (Shandong Academy of Medical Science)

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

肺超声评分

指标类型:

主要指标

Outcome:

lung ultrasound scores

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

preoperative, after intubation, 5 min aftertrendelenburg position, immediately after surgery, before discharge from PACU

Measure method:

指标中文名:

白介素-6

指标类型:

次要指标

Outcome:

IL-6

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

CC-16

指标类型:

次要指标

Outcome:

CC-16

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肺表面活性物质

指标类型:

次要指标

Outcome:

Sufactant protein A

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

呼吸力学指标

指标类型:

次要指标

Outcome:

respiratory mechanic

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生命体征

指标类型:

附加指标

Outcome:

vital signs

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由研究者使用计算机产生的随机数字表,按照1:1比例随机分两组 http://www. randomization.com

Randomization Procedure (please state who generates the random number sequence and by what method):

Simple randomisation was performed by the principal investigator using a computer-generated randomisation software(Randomization.com; http://www. randomization.com) with an allocation ratio of 1:1.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

单盲

Blinding:

Single blind method

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

根据需要,可向研究者提出合理要求共享数据

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The data can be requested from the principal investigator with reasonable cause

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表,电子采集和管理系统:ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF.EDC:ResMan

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-07-26 11:41:45